Herbs (Global Traditional) · African
Tithonia diversifolia (Mexican Sunflower)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Tithonia diversifolia is a medicinal plant containing flavonoids and sesquiterpene lactones that exhibits anti-inflammatory, antidiabetic, and hepatoprotective properties. Its primary mechanism involves inhibiting pro-inflammatory cytokines like TNF-α and IL-1β while modulating glucose metabolism.
Tithonia diversifolia, commonly known as Mexican Sunflower, is a perennial herbaceous plant in the Asteraceae family native to Mexico and Central America but widely naturalized in tropical regions including Indonesia, South Africa, and parts of Asia. The medicinal parts are primarily the leaves, from which extracts are obtained via ethanolic extraction, aqueous extraction, or suspension in 0.1% sodium carboxymethyl cellulose (CMC-Na) for oral administration.
All available evidence is limited to preclinical studies in animals and cell lines, with no human clinical trials identified. Key animal studies include a randomized posttest control group design in 24 STZ-induced diabetic rats showing significant reduction in inflammatory markers (PMID: 39553780), and a mouse study demonstrating anti-inflammatory effects at doses of 0.1-3 mg/kg (PMID: 31252095). A review of 168 studies confirmed preclinical support but noted the complete absence of human data (PMID: 29596999).
In animal studies only: 100 mg/kg body weight daily for diabetes management in rats, or 0.1-3 mg/kg for anti-inflammatory effects in mice. No human dosage data exists. Extracts were crude leaf preparations without standardization. Consult a healthcare provider before starting any new supplement.
Tithonia diversifolia (Mexican Sunflower) contains a diverse array of macronutrients, micronutrients, and bioactive compounds. Leaves contain approximately 20–28% crude protein on a dry weight basis, making them notably protein-rich compared to many forage plants. Crude fiber ranges from 15–25% dry weight, with moderate fat content (~4–6% dry weight). Carbohydrates constitute roughly 40–50% dry weight. Key micronutrients include calcium (~1.2–2.0% dry weight), phosphorus (~0.2–0.4% dry weight), magnesium (~0.4–0.6% dry weight), potassium (~2.0–3.5% dry weight), and iron (~200–400 mg/kg dry weight). Zinc (~30–60 mg/kg), manganese (~150–250 mg/kg), and copper (~10–20 mg/kg) are also present. Bioactive compounds are the primary pharmacological interest: sesquiterpene lactones (tagitinin A, B, C, F; diversifolide) at approximately 0.1–0.5% dry weight — these are considered the principal anti-inflammatory and antidiabetic agents linked to TNF-α/IL-1β suppression and blood glucose lowering at 100 mg/kg in rat models (PMID: 39553780; PMID: 31252095). Flavonoids (quercetin, kaempferol, luteolin derivatives) are present at ~0.5–1.5% dry weight and contribute antioxidant activity. Phenolic acids including chlorogenic and caffeic acids are detected at ~0.2–0.8% dry weight. Saponins (~1–3% dry weight) and tannins (~0.5–1.5% dry weight) are present and may reduce bioavailability of minerals and proteins through chelation and protein-binding, respectively. Terpenoids including diterpenes and triterpenes (e.g., lupeol, β-sitosterol) contribute to hepatoprotective and nephroprotective effects observed via reduced SGOT/SGPT in diabetic models. Bioavailability notes: The presence of tannins and saponins may reduce mineral absorption (particularly iron, zinc, calcium) and protein digestibility by 10–30% if consumed raw. Heat processing or fermentation is recommended to improve bioavailability. Sesquiterpene lactones are fat-soluble and absorption may be enhanced with dietary fats. Flavonoid bioavailability is moderate; gut microbial metabolism plays a significant role in activating phenolic precursors. Overall, the plant is best considered a functional/medicinal ingredient rather than a primary nutritional source, with bioactive compound concentrations varying significantly by plant part (leaves > stems > roots), growth stage, and geographic origin.
Tithonia diversifolia contains flavonoids and sesquiterpene lactones that suppress inflammatory cytokines TNF-α and IL-1β while reducing neutrophil migration. The plant's compounds appear to modulate glucose metabolism pathways and protect hepatic tissue by decreasing liver enzyme levels (SGOT/SGPT). These mechanisms suggest multi-target activity involving both inflammatory and metabolic pathways.
Current evidence for Tithonia diversifolia comes primarily from animal studies with limited human data. In diabetic rat models, 100 mg/kg dosing significantly reduced blood glucose levels. Anti-inflammatory studies in mice demonstrated measurable reductions in TNF-α, IL-1β, and neutrophil migration markers. Hepatoprotective effects showed decreased SGOT/SGPT enzyme levels, though complete study data remains limited.
Safety data for Tithonia diversifolia supplementation is extremely limited with no established human dosing guidelines. Potential interactions with diabetes medications could cause hypoglycemia due to glucose-lowering effects observed in animal studies. Individuals with liver conditions should exercise caution given the plant's hepatoactive properties. Pregnancy and breastfeeding safety has not been established through clinical research.
